PATENT CLAIM ANALYSIS

Application Number: 15766680
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "604000"]

Abstract:
Cancer is a disease for which there remains a great unmet medical need, and therefore the discovery and development of new antineoplastic agents is critically important. The present invention relates in part to new therapeutic compounds with antineoplastic activity. Provided herein are polyamine sulfonamides such as compounds of Formula (I), or pharmaceutically acceptable salts thereof, which may be used in the treatment and/or prevention of diseases such as cancer. Also provided herein are pharmaceutical compositions and kits comprising the inventive compounds. Furthermore, the present invention provides methods of treating and/or preventing diseases (e.g., cancer) using compounds of Formula (I), or pharmaceutically acceptable salts thereof or pharmaceutical compositions thereof. Other methods provided include methods for inducing apoptosis of a cell, as well as methods for inhibiting alpha-enolase enzymatic activity in vivo and in vitro.

Claim (Index 45):
The compound of  claim 4 , wherein the compound of Formula (III) is one of the following formulae: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 91.0
- Lexical Diversity: 1.78824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15847856', '16095188', '14907339', '14358606', '15188545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8401644859779004
- 35 USC 102 Novelty (BERT): 0.5641825310026293
- Combined Prediction Score: 0.8125662904803733
- Mean Citation Score: 490.935518
- Max Citation Score: 498.63635
- Similarity Product: 331.9040655542701

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test